MEDTRONIC EUROPE SARL CLARIA MRI QUAD CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
|
Back to Search Results |
|
Model Number DTMA1QQ |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bruise/Contusion (1754); Hematoma (1884); Pain (1994); Swelling/ Edema (4577)
|
Event Date 02/04/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: 6935m62 lead, implanted (b)(6) 2014; 439888 lead, implanted (b)(6) 2023.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported by the patient that the cardiac resynchronization therapy defibrillator (crt-d) was very pronounced and noticeable a few weeks after surgery.The patient reported experiencing pain, bruising, and swelling around the pocket post implant that was subsiding daily.Prior to that, the patient had been seen three days after the implant procedure for an incision check and at that time was found to have a small pocket hematoma.The hematoma was stable and the patient was advised to continue their anti-coagulant medication.Approximately a week later, after resuming their medication the patient noted that the swelling had increased slightly.The nurse noted that the hematoma looked worse; though no active bleeding.Staples were removed and the wound was stable with mild, superficial ooze.Two days later, the patient was seen in office with a large pocket hematoma along with pain at the site.The patient was hospitalized and the pocket was opened and the hematoma was evacuated; the pocket was irrigated with antibiotic solution.Prior to the evacuation, the device was tachy therapies were deactivated.After the procedure the device was placed back into its original settings.The crt-d remains in use.The patient is a participant in a clinical study.No further patient complications have been reported as a result of this event.
|
|
Search Alerts/Recalls
|
|
|